RIGL
Rigel Pharmaceuticals
$50.74
+$0.19 (+0.38%)Oct 28, 2026
Key metrics
The numbers that frame RIGL today
- Market cap
- $947.82M
- P/E (TTM)
- 3.0
- EV / FCF
- 102.5
- Gross margin
- 91.4%
- EV / Sales
- 3.3
- ROIC
- 29%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $24.95
- 52wk High
- $52.24
Growth
Revenue and earnings trend for RIGL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RIGL
Is Rigel Pharmaceuticals a good buy?
Yes. Rigel Pharmaceuticals has excellent momentum, and it outweighs the weak quality here. Growth looks mixed. The support signal is useful, but not decisive. We think Rigel Pharmaceuticals is selling at a fair price.
What is the market capitalization of RIGL?
Rigel Pharmaceuticals's market capitalization is $947.82M.
What is the P/E (TTM) ratio for RIGL stock?
Rigel Pharmaceuticals's P/E (TTM) ratio is 3, based on trailing earnings.
What is the 52-week high for RIGL stock?
The 52-week high for Rigel Pharmaceuticals is $52.24. The current close of $50.74 is 2.9% below that high.
What is the 52-week low for RIGL stock?
The 52-week low for Rigel Pharmaceuticals is $24.95. The current close of $50.74 is 103.4% above that low.
Does RIGL stock pay dividends?
Rigel Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RIGL?
Rigel Pharmaceuticals's Debt / Equity ratio is 0.09.